Insights

Gathering insights about Bolt…

Similar companies to Bolt

Bolt Tech Stack

Bolt uses 8 technology products and services including Triblio, Varnish, Font Awesome, and more. Explore Bolt's tech stack below.

Triblio
Account-based Marketing
Varnish
Caching
Font Awesome
Font Scripts
Asana
Issue Trackers
Android
Programming Languages
Google Tag Manager
Tag Management
BrowserStack
Testing And Qa
Pinterest
Widgets

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)
Toronto, Ontario--(Newsfile Corp. - Le 11 novembre/November 2024) - Bolt Metals Corp. has announced a two (2) for one (1) stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive one (1) additional share for each share held on such date.
Nov 11, 2024 | www.newsfilecorp.com
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from BDC-1001 data suggest Boltbody™ ISACs with enhanced immune activation could offer greater efficacy, warranting further testing REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today presented updated preclinical data for BDC-4182, a next-generation Boltbody™ ISAC clinical candidate targeting claudin 18.2, and provided key learnings from its Phase 1 dose-escalation trial of BDC-1001 at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held in Houston, Texas from November 6-10, 2024.
Nov 07, 2024 | www.globenewswire.com
Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 06, 2024 | www.accesswire.com
The Schall Law Firm Invites Investors To Contribute To A Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 05, 2024 | www.accesswire.com
Bolt Biotherapeutics Announces Changes to its Board of Directors
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Jakob Dupont, M.D., to its Board of Directors. Dr. Dupont brings more than two decades of experience in the field of oncology and immuno-oncology. With the appointment of Dr. Dupont, Executive Partner at Sofinnova Investments, Dr. Jim Healy, M.D., Ph.D., also at Sofinnova, will be stepping down as Lead Independent Director. In addition, Frank D. Lee will be departing the Board and Brian O'Callaghan, CEO of Deep Genomics, will be assuming the role of Chair.
Sep 04, 2024 | www.globenewswire.com
Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 04, 2024 | www.accesswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT
NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT) and certain officers.
Sep 03, 2024 | www.prnewswire.com

Bolt's Email Address Formats

Bolt uses at least 1 format(s):

Bolt Email Formats	Example	Percentage
FirstLast@bolt.com	JohnDoe@bolt.com	85%
First@bolt.com	John@bolt.com	6%
FLast@bolt.com	JDoe@bolt.com	6%
First.Last@bolt.com	John.Doe@bolt.com	3%

Frequently Asked Questions

Where is Bolt's headquarters located?

Bolt's main headquarters is located at 588 Sutter St San Francisco, California 94102 US. The company has employees across 6 continents, including North AmericaAfricaAsia.

What is Bolt's phone number?

You can contact Bolt's main corporate office by phone at

+1-212-608-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bolt's stock symbol?

Bolt is a publicly traded company; the company's stock symbol is BOLT.

What is Bolt's official website and social media links?

Bolt's official website is bolt.com and has social profiles on LinkedIn.

How much revenue does Bolt generate?

As of November 2024, Bolt's annual revenue reached $75M.

What is Bolt's NAICS code?

Bolt's NAICS code is 5112 - Software Publishers.

How many employees does Bolt have currently?

As of November 2024, Bolt has approximately 746 employees across 6 continents, including North AmericaAfricaAsia. Key team members include Chief Executive Officer: A. Y.Chief Product Officer: K. R.Chief Revenue Officer: T. S.. Explore Bolt's employee directory with LeadIQ.

What industry does Bolt belong to?

Bolt operates in the Software Development industry.

What technology does Bolt use?

Bolt's tech stack includes TriblioVarnishFont AwesomeAsanaAndroidGoogle Tag ManagerBrowserStackPinterest.

What is Bolt's email format?

Bolt's email format typically follows the pattern of . Find more Bolt email formats with LeadIQ.

When was Bolt founded?

Bolt was founded in 2014.

Bolt

Software DevelopmentCalifornia, United States501-1000 Employees

Household name retailers use Bolt's leading commerce platform to convert, retain, and delight more shoppers—all within the merchant's existing tech stack and brand identity.

Learn how it works here: https://www.bolt.com/bolt-ignite

Apply to join us here: https://www.bolt.com/careers/